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Abstract
Background: Delirium is a serious and distressing neurocognitive disorder of physiological aetiology that is
common in advanced cancer. Understanding of delirium pathophysiology is largely hypothetical, with some
evidence for involvement of inflammatory systems, neurotransmitter alterations and glucose metabolism. To date,
there has been limited empirical consideration of the distinction between delirium pathophysiology and that of the
underlying disease, for example, cancer where these mechanisms are also common in advanced cancer syndromes
such as pain and fatigue. This systematic review explores biomarker overlap in delirium, specific advanced cancer-
related syndromes and prediction of cancer prognosis.
Methods: A systematic review (PROSPERO CRD42017068662) was conducted, using MEDLINE, PubMed, Embase,
CINAHL, CENTRAL and Web of Science, to identify body fluid biomarkers in delirium, cancer prognosis and
advanced cancer-related syndromes of interest. Studies were excluded if they reported delirium tremens only; did
not measure delirium using a validated tool; the sample had less than 75% of participants with advanced cancer;
measured tissue, genetic or animal biomarkers, or were conducted post-mortem. Articles were screened for
inclusion independently by two authors, and data extraction and an in-depth quality assessment conducted by one
author, and checked by two others.
Results: The 151 included studies were conducted in diverse settings in 32 countries between 1985 and 2017,
involving 28130 participants with a mean age of 69.3 years. Seventy-one studies investigated delirium biomarkers,
and 80 studies investigated biomarkers of an advanced cancer-related syndrome or cancer prognosis. Overall, 41
biomarkers were studied in relation to both delirium and either an advanced cancer-related syndrome or prognosis;
and of these, 24 biomarkers were positively associated with either delirium or advanced cancer syndromes/
prognosis in at least one study. The quality assessment showed large inconsistency in reporting.
Conclusion: There is considerable overlap in the biomarkers in delirium and advanced cancer-related syndromes.
Improving the design of delirium biomarker studies and considering appropriate comparator/controls will help to
better understanding the discrete pathophysiology of delirium in the context of co-existing illness.
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Background
Delirium is a very common cause of acute cognitive
change in people with advanced cancer [1] and is associ-
ated with increased morbidity and mortality [2, 3]. Delir-
ium is a serious and complex neurocognitive disorder
characterized by acute deterioration in attention, aware-
ness and cognition, variously affecting memory, language
and visuospatial ability, orientation and perception [4].
Delirium occurs in people who are medically unwell,
due to the underlying disease which has put them at risk
(e.g. dementia, cancer, infection, renal impairment) or
intercurrent problems, and the subsequent medical
treatment (e.g. surgery, medication) . Delirium can occur
for any person, with those who are older, have advanced
illness, and/or prior cognitive impairment most at risk
[5]. The prevalence of delirium in patients with ad-
vanced cancer in oncology and palliative care settings is
higher than that in most other settings, including geriat-
rics [1, 6–9]. A systematic review of palliative care pa-
tients (with 98.9% of participants with advanced cancer),
reported delirium incidence rates between 3% and 45%.
Delirium prevalence ranged from 13.3% to 42.3% at ad-
mission to hospital, and 25% to 62% during admission.
Delirium prevalence increased up to 88% in the hours to
days before death [1].
The pathophysiology of delirium is poorly understood,
and largely hypothetical. Current hypotheses include:
neuronal ageing, neuroinflammation, oxidative stress,
neuroendocrine dysregulation, disruption to the circa-
dian rhythm, and neurotransmitter dysregulation [10,
11]. A reduction in glucose metabolism seen in people
with delirium is a model with developing evidence [12,
13]. Collectively, the biological correlates of delirium are
referred to as ‘delirium biomarkers’. A biomarker is a
biological molecule found in blood, other body fluids, or
tissues that is a sign of a normal or abnormal process, or
of a condition or disease [14]. Biomarkers are most com-
monly studied to investigate their correlation with a dis-
ease in order to better understand its underlying
pathophysiology, and subsequently inform prevention
and treatment strategies for that disease. A challenge for
the field of delirium research is that correlation may
exist between biomarkers of delirium and those of the
patient’s disease or injury which placed them at in-
creased risk of delirium, or which precipitated it (for ex-
ample sepsis or hip fracture). Such correlation should be
factored into delirium biomarker research, yet rarely has
been. Better understanding of the interplay between de-
lirium pathophysiology and that of correlated conditions
and diseases, for example, cancer (the focus of this re-
view), is crucial to develop more effective prevention
and treatment of delirium.
We therefore conducted a systematic review of the lit-
erature to explore the overlap between biomarkers that
have been studied in delirium and biomarkers that have
been studied in cancer-related syndromes. Our aim was
to identify biomarkers associated with delirium and with
specific clinical situations in advanced cancer (namely
prognosis; cognitive impairment, anorexia cachexia, can-
cer pain, cancer-related fatigue, and sickness behavior);
and to evaluate the nature and extent of overlap of the
findings.
Methods
A systematic review according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) [15] was conducted. In July 2017, two separate
searches were conducted in MEDLINE, PubMed, Embase,
CINAHL, CENTRAL, and Web of Science. The first was
for literature of delirium biomarkers; the second was for
literature of biomarkers in advanced cancer-related syn-
dromes. Primary terms for the delirium search were: ‘de-
lirium’ and ‘biomarker’. Search terms for the cancer
search were: ‘cancer’, ‘neoplasms’, ‘metastasis’, ‘fatigue’,
‘sickness behavior’, ‘cancer pain’, ‘cachexia’, and ‘progno-
sis’. Additional terms which encompassed commonly
researched biomarkers were also included. Filters in Med-
line were: 1: Humans; 2. English language and 3. Published
from 1980 onward (when delirium was first included in
the DSM, Third Edition (DSM-III)). Search terms and fil-
ters were tailored to each subsequent database, as re-
quired. The full search strategy is provided in Additional
file 1. Reference lists of included studies and relevant sys-
tematic reviews and meta-analyses identified in the search
were examined for additional eligible studies.
We included English language studies published in
peer-reviewed journals that reported body fluid bio-
markers in adult participants with delirium, cancer prog-
nosis or an advanced cancer-related syndrome of
interest. Studies were excluded if they reported delirium
tremens only; did not measure delirium using a validated
tool; the sample had less than 75% of participants with
advanced cancer; measured tissue, genetic or animal bio-
markers, or were conducted post-mortem. Protocols and
ongoing studies were also excluded. Based on the expert
knowledge of the authors in both delirium and cancer,
the advanced cancer-related syndromes and prognosis
were chosen based on the potential biological plausibility
that the pathophysiological mechanisms could overlap
with that of delirium. We limited the search to advanced
cancer as this is the cancer population with the highest
prevalence of both delirium and the cancer-related syn-
dromes of interest.
The following definitions were used in this review:
Anorexia cachexia: A complex metabolic syndrome of
involuntary weight loss associated with cancer and
some other palliative conditions [16].
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Cancer related fatigue: A distressing, persistent,
subjective sense of physical, emotional, and/or cognitive
tiredness or exhaustion related to cancer and/or cancer
treatment that is not proportional to recent activity and
interferes with usual functioning [17].
Cancer-related pain: An unpleasant sensory and
emotional experience associated with actual or
potential tissue damage, or described in terms of such
damage [18].
Cancer-related cognitive impairment: Cognitive
impairment that is commonly experienced by cancer
patients and those in remission. The cognitive domains
most commonly affected are memory, concentration,
information processing speed and executive function
[19].
Sickness behaviour: The coordinated set of behavioural
changes that develop in sick individuals during the
course of an infection. Sickness behavior is also seen in
other illness including cancer [20, 21].
Cancer prognosis: The likely outcome or course of the
disease; the chance of recovery or recurrence. Cancer
prognosis is assessed by cancer-specific survival, overall
survival, progression free survival or relative survival [22].
Search results were imported into Endnote X7 soft-
ware, duplicates removed and then exported into Covi-
denceTM (www.covidence.org). Two reviewers per search
(IAD and AH: delirium search, IAD and MA: cancer
search) independently applied eligibility criteria for both
searches and examined title and abstracts. Exclusions
were documented only for articles that required full-text
to make a formal decision. Inter-reviewer disagreement
on included studies was discussed to resolve any discrep-
ancies, with the third reviewer consulted when required.
Data extraction was conducted by one reviewer (IAD)
using Excel (2016) with two other reviewers (MA and
AH) providing input and oversight. Data extraction was
guided by the REporting recommendations for tumor
MARKer prognostic studies (REMARK) checklist [23].
In the absence of a gold standard risk of bias assess-
ment for biomarker studies, one reviewer (IAD) applied
an adaptation of the REMARK checklist [23] to assess
the methodological quality of the included studies, with
10% verification by two other reviewers (MA and AH).
The heterogeneity of data precluded performing a
meta-analysis; we therefore reported the data using a
narrative synthesis approach with text and tabular sum-
maries. The synthesis was structured according to the
overlap of the biomarkers in delirium, cancer prognosis
and the cancer syndromes, the biomarker type, assay
used, and numbers and proportions of participants who
had delirium and advanced cancer. We defined ‘overlap’
as any biomarker that was studied in both a delirium
study and an advanced cancer syndrome study.
Results
The delirium search yielded 3342 articles and the cancer
syndromes search 4081, giving a total of 7423 articles.
An additional 25 articles were found through the hand
search. After removal of 1817 duplicates and 5120 arti-
cles through title and abstract screening, we reviewed
511 full text papers and subsequently excluded 288.
After initial analysis, a further 72 were excluded as they
did not report a biomarker studied in delirium and ad-
vanced cancer. This resulted in a total of 151 articles in-
cluded in this review: 71 reported biomarkers studied in
delirium, and 80 reported biomarkers studied in a cancer
syndrome or prognosis (Figure 1).
The 151 studies were conducted between 1985 and
2017 in Europe (n=86), Asia (n=33), The Americas (n=
27), Australia (n=2), and multiple regions (n=3). Studies
were set in a large range of settings, with the most com-
mon in general hospital settings (n=111; 73%). Thirty-
nine studies (26%) did not report the setting. Sample
sizes ranged from 7-2456, with relatively even numbers
of male and female participants (55.4% male). Ninety
nine articles reported a mean age, with an overall
weighted mean age of 69.3 years. Of the 37 articles that
reported the median age of participants, the overall me-
dian age was 54.5 years. The overall age of participants
in the remaining 15 articles was not possible to deter-
mine (Additional files 2 and 3). Blood biomarkers were
examined in 138 studies, 4 studies examined biomarkers
in cerebrospinal fluid (CSF), 3 in urine, and 16 (11%) did
not report the type of biological material. Of the studies
that reported the assay technique, diverse assays were
used (n=20), with Enzyme-linked immunosorbent assay
(ELISA) being the most common (n=62; 58%). Forty-
four studies (29%) did not report the specific assay used.
Of these, 21 studies (48%) were routinely measured bio-
markers (Tables 1 and 2).
A total of 41 biomarkers were found to be common in
both delirium and advanced cancer syndrome studies.
The five most commonly studied biomarkers were C-
reactive protein (CRP) (n=79), interleukin (IL)-6 (n=58),
tumor necrosis factor alpha (TNF- α) (n=42) IL-10 (n=
21) and IL-8 (n=24). Of these, 24 biomarkers had a posi-
tive association with delirium, cancer prognosis or a can-
cer syndrome in at least one study. No cancer studies
reported having any participants with delirium, and of
the delirium studies, six reported participants with can-
cer. Figure 2 illustrates two main populations identified
from this systematic review, with the centre showing the
‘true overlap’ defined as studies that included partici-
pants with both delirium and cancer (n=6 studies).
In two of these studies, all participants in the study
had cancer; in another, 64.2% of participants had cancer;
in the remaining three studies, less than 30% of all par-
ticipants had cancer. In three of the studies, 100% of
Amgarth-Duff et al. BMC Psychiatry          (2020) 20:182 Page 3 of 32
Fig. 1 PRISMA flow diagram of search results
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participants who had delirium also had cancer, in an-
other two, 26% and 27% of the delirium cohorts had
cancer, and in the remaining study 14% of the delirium
participants had cancer (Table 1). Although only six de-
lirium studies reported co-existing cancer, there is still
uncertainty as to how many participants in both groups
of studies had both delirium and cancer. The two most
common biomarkers in these six studies that reported a
positive association with delirium were CRP (n=3) and
IL-6 (n=3). It is unclear however whether these bio-
markers were predominantly associated with delirium or
the cancer, as three of the six studies grouped the delir-
ium participants together, irrespective of their cancer
comorbidity.
The quality assessment showed a large variability in
the reporting of included studies. 150 (99%) studies had
a clear aim statement which included their outcome of
interest. One study did not report a clear aims statement
[175]. One hundred and nineteen studies (79%) did not
explicitly state the hypothesis; however, in most (n=94;
62%) the hypothesis could be interpreted by the study
aim. All 151 studies stated the participant population in
detail. No study reported all elements of the assay
methods in the REMARK checklist [23]. One hundred
and thirty one studies (87%) did not report whether as-
says were blinded to the study endpoint, however 59
(45%) of those studies were objective assessments. Fur-
ther, 14 studies (9%) reported a power calculation to jus-
tify their sample size. Most (n=125; 83%) of studies
defined all clinical endpoints examined. Ninety seven
(64%) studies undertook multivariate analysis, and of
these 67 (69%) described the multivariate model and the
covariates included in the model, and 23 (23%) explained
the rationale for inclusion of the covariates in the
models. (Additional files 4 and 5). Furthermore, 27 delir-
ium studies (38%) did not report the reason for admis-
sion. Of the 44 studies that did report the reason for
admission, these were predominantly for surgery-
elective and acute (n=40). Most studies in the non-
surgical population did not report a reason for admis-
sion, with the exception of 4 studies where the medical
condition of interest occurred on admission (e.g stroke).
See additional files 4 and 5 for the complete quality
assessments.
The methodological quality of the assay procedures
only is depicted in Figure 3, with reporting of type of
biological material mostly provided but much lower fre-
quency of reporting for other critical descriptors.
Discussion
This is the first systematic review to our knowledge, to
demonstrate the high degree of overlap in biomarkers in
delirium, cancer prognosis and advanced cancer syn-
dromes. This systematic review of 151 studies found that
41 biomarkers were independently investigated in stud-
ies of both delirium and prognosis/advanced cancer syn-
dromes; with over half having a positive association in at
least one study.
Biomarkers fall into three categories (though not mu-
tually exclusive); those which present before disease on-
set that can help identify individuals who are most at
risk of a particular disease (for example, genetic
markers), those which are disease markers and as such,
increase during disease progression and decrease after
resolution, and thirdly, biomarker as an end-product of
a disease for which levels are proportionate to ‘damage’
due to the disease [176]. The findings of this systematic
review suggest that categorization along these lines is
less understood in delirium. For example, there is evi-
dence to show that conditions such as sepsis and hip
fracture cause changes in inflammatory markers [177,
178], however, there is little evidence about whether de-
lirium self-propagates. Some animal model data in delir-
ium suggests that there might be a direct impact of
inflammatory markers on brain dysfunction [179]. To
our knowledge there was no published relationship be-
tween tumor markers and neurological brain dysfunc-
tion. Although clinical evidence suggests long term
impacts on brain function, the exact pathophysiological
mechanisms are poorly understood, and biomarkers to
measure this are also unclear.
The issue of biomarker overlap between associated
conditions has been researched in women with pre-
eclampsia and polycystic ovary syndrome [180], however
the overlap with respect to delirium and its associated
conditions has not been well addressed. Of the 71 delir-
ium studies, only five studies sought to determine the as-
sociation with the participants’ common primary
condition in their analysis. Tomasi et al. (2017) found
that biomarkers differed between patients in the three
groups in those with sepsis alone and those who devel-
oped sepsis-associated encephalopathy, or delirium,
Fig. 2 Conceptual model illustrating the ‘true overlap’ of delirium
and advanced cancer biomarker studies. * Cancer as a comorbidity
not measured/reported # Delirium as a concurrent illness or
comorbidity not measured/reported
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suggesting different mechanisms of sepsis-associated en-
cephalopathy, delirium in people with sepsis, and sepsis
itself. Likewise, Pfister et al. (2008) found differences in
CRP, s100 calcium binding protein B (s100B) and
cortisol in patients with sepsis-associated delirium,
compared to non-sepsis associated delirium. In two
studies, delirium in stroke was examined [25, 92] but
these studies did not identify differences in cortisol
[92] or TNF- α, IL- 1β, IL-18, Brain-derived neuro-
trophic factor (BDNF) and Neuron specific enolase
(NSE) [25] between patients who developed delirium
after stroke compared to those who did not develop
delirium. Moreover, Sun et al. (2016) attempted to
explore the overlap of biomarkers in delirium and de-
mentia in patients with cancer, however, no multivari-
ate analysis was undertaken, therefore results of this
study are inconclusive.
Although the aim of this systematic review was to ex-
plore the overlap of biomarkers in delirium and ad-
vanced cancer syndromes, the findings highlighted a
bigger problem in the methodology of delirium bio-
marker research. The quality assessment in this system-
atic review found that many of the included studies were
of poor methodological quality, inadequately reported,
or were influenced by potential confounding factors. A
potential barrier to the complete understanding of delir-
ium pathophysiology is the lack of guidelines for con-
ducting and reporting delirium biomarker studies.
Results from this review indicate that the absence of
such guidelines has likely impeded the quality of individ-
ual studies and the overall quality of this critical field of
delirium research. Reporting guidelines for delirium bio-
marker research are an essential step to improving
methodological and reporting rigor, and will increase the
potential for synthesis of future studies through meta-
analyses.
Several studies have previously been performed to de-
termine biomarkers associated with delirium, however
potential confounding factors could be the underlying
precipitants of delirium; ie risk factors (sepsis), or
underlying conditions present (for example cancer or de-
mentia). The top five most commonly studies bio-
markers in this review were inflammatory biomarkers,
namely, CRP, IL-6, TNF- α, IL-10 and IL-8. The chal-
lenge with inflammatory markers is that they are non-
specific and the inflammatory pathways are similar to
those implicated in other conditions such as sepsis and
depression [181, 182]. Likewise, of the six delirium stud-
ies where there was concomitant cancer, it is very diffi-
cult to determine whether those biomarkers found were
related to the cancer or the delirium itself, considering
alterations in inflammatory pathways are implicated in
both. Therefore, future delirium biomarker studies need
to be prospectively evaluated and take into account and
assess robustly other active co-morbidities such as can-
cer that could plausibly impact on the pathophysio-
logical and/or biological findings. Similarly, future
cancer biomarker studies must also take into account
how delirium may clinically or biologically confound
biomarker studies in cancer, considering the high preva-
lence of delirium in this population. Of the six delirium
studies with cancer, three did not report the type of can-
cer, and of the remaining three studies, none were pri-
mary brain tumours or brain metastases. Understanding
the spread of brain cancer is important in delirium stud-
ies, and is an important consideration for future delirium
biomarker studies.
Majority of the studies in this review (n=98; 65%)
undertook a multivariate analysis, taking into account
confounding variables. Where studies only undertook
univariate analysis, it is uncertain whether any observed
changes in biomarkers were related to the delirium itself,
or whether these changes may have been lost when ad-
justed for confounding factors (such as prior cognitive
impairment) in a multivariate analysis. Furthermore,
there is likely to be a higher proportion of participants
with both delirium and cancer in both groups of studies
for which this clinical information was not assessed or
that were not reported. Key methodological issues which
need to be addressed in future delirium studies include
Fig. 3 Quality assessment graph of the assay procedures: review author’s judgements about each assay domain of the REMARK checklist,
presented as percentages across studies
Amgarth-Duff et al. BMC Psychiatry          (2020) 20:182 Page 26 of 32
adjusting for confounders such as age, gender, concur-
rent medication, comorbidities, prior cognitive impair-
ment, frailty and other neurological conditions. These
clinical covariates must also be clearly defined and justi-
fied. Assay procedures ought to be reported in detail, in-
cluding a detailed protocol of the reagents/kits used,
repeatability assessments, methods of preservation and
storage, assay validity, sensitivity limits of the assay and
a scoring and reporting protocol. The timing of the assay
is crucial in delirium studies, and the fluctuating patho-
physiological processes occurring during delirium, after
delirium resolution, and in those who have not yet de-
veloped delirium, must be taken into consideration, and
be separated in future studies. More standardised and
detailed methods of delirium biomarker studies is a cru-
cial step in carrying out future subgroup analyses within
this cohort and improving the overall understanding of
delirium pathophysiology.
Limitations are that only English language and pub-
lished studies were included. It is possible that articles
were missed; however, two reviewers independently
screened all citations derived from a search of six rele-
vant and diverse databases, and all reference lists of in-
cluded articles were also searched. Another limitation of
our study is the lack of a risk of bias tool for biomarker
studies, therefore we used an adaptation of tumor
marker reporting guidelines, the REMARK checklist
[23]. Lastly, the heterogeneity of the data precluded the
conduct of a meta-analysis, and precluded any firm con-
clusions about the biomarkers in delirium and cancer,
thus, limiting the rigor of this review. Strengths of this
review however, were that we undertook a systematic
approach adhering to the PRISMA [15] and an extensive
quality assessment of the included studies was
undertaken.
Conclusion
This review found that there is large overlap in the bio-
markers in delirium and in advanced cancer-related syn-
dromes, although because of the heterogeneity of the
studies firm conclusions about the true overlap of delir-
ium and advanced cancer syndrome biomarkers was not
possible. More robust conduct and reporting of delirium
biomarker studies will help to better understand the
pathophysiology of delirium in the context of co-existing
pathophysiology. An improved understanding of the
clinical and biological associations of delirium and ad-
vanced cancer syndromes in future prospective studies
will provide and inform the directions of research into
delirium in people with advanced cancer.
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